Knopp Biosciences Announces Publication of Eosinophil-lowering Effects of Dexpramipexole in Multiple Clinical Trials

Knopp Biosciences LLC announced the publication of results from multiple clinical trials demonstrating the eosinophil-lowering effects of dexpramipexole, a small molecule treatment in development for eosinophil-associated diseases. “The totality of the evidence to date, across multiple clinical studies in multiple … Continued